| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9340923 | Urologic Oncology: Seminars and Original Investigations | 2005 | 7 Pages |
Abstract
No single-agent activity of lonafarnib was observed in this study of patients with aggressive TCC failing prior chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Eric M.D., M.Sc., Malcolm J. M.D., Kim N. M.D., D. Scott M.D., Hal M.D., Scott M.D., Jean Powers, Wendy M.Sc., Therese Boucher, Robert Ph.D., Lesley M.D.,